Skip to content

Homoeopathic treatment of knee osteoarthritis

A randomized, double-blind, placebo-controlled, pilot experiment of individualized homoeopathic medicines in knee osteoarthritis

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/10/028711
Enrollment
72
Registered
2020-10-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M179- Osteoarthritis of knee, unspecified

Interventions

dosage and repetition depending upon the individual requirement of the cases. Management guidelines will be given as in the experimental arm. Duration of therapy: 3 months. Control Intervention2: Plac
dosage and repetition depending upon the individual requirement of the cases. General management will include ice cube massage over the painful knee(s), static quadriceps exercise, use of knee cap or

Sponsors

D N De Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age 50-70 years 2. Patients of either sex 3. Diagnosed knee OA as per American College of Rheumatology (ACR) clinical/radiographic classification criteria: a) Knee pain b) At least 1 of 3: age more than 50 years, stiffness less than 30 min, and crepitus on knee motion c) Osteophytes on knee x-ray 4. Patients already undergoing regular oral or topical analgesics or NSAID therapy for painful episodes of OA, provided the medications are stopped completely at least 2 weeks prior study entry 5. Literate patients; can read Bengali or English 6. Providing written informed consent

Exclusion criteria

Exclusion criteria: 1. Severe degeneration of knee joint with marked joint narrowing, varus, or valgus deformity of knee ( >12°), evidenced by imaging or other evidences and requiring surgical intervention 2. Non-ambulant patients 3. Self-reported joint disorders other than osteoarthritis (e.g., inflammatory joint disease, specific arthropathy, hyperuricaemia and/or gout, severe axis deviations or instabilities, joint or skin infections, joint prostheses of the lower limbs) 4. Intra-articular injections within 2 weeks before study entry 5. Transplanted knees 6. Recent significant knee surgery within last 6 months 7. Patients who are too sick for consultation 8. Unwilling to take part and not giving consent to join the study 9. Unable to read patient information sheet 10. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life 11. Pregnancy, puerperium and lactation 12. Substance abuse and/or dependence 13. Self-reported immune-compromised state, and 14. Undergoing homoeopathic treatment for any chronic disease within last 6 months.

Design outcomes

Primary

MeasureTime frame
Knee injury and osteoarthritis outcome scores (KOOS)Timepoint: At baseline and every month up to 3 months

Secondary

MeasureTime frame
Frequency of add-on paracetamol and/or NSAIDs (oral/topical) during study periodTimepoint: At baseline and every month up to 3 months;Measure yourself medical outcome profile version-2 (MYMOP-2)Timepoint: At baseline and every month up to 3 months

Countries

India

Contacts

Public ContactProf Dr Shyamal Kumar Mukherjee

D. N. De Homoeopathic Medical College and Hospital

drkisorkumarnaskar@gmail.com9433039891

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026